StocksDeepDive
Snapshot · TOPIX 500 · generated 2026-11-11 21:48 UTC

4502.T — Takeda Pharmaceutical Company Limited

UNDERVALUED (MOS +33.2%) · Quality 58/100

Value Score 30 days ago: 34.8 → today 30.7

Price
6673
Intrinsic value
9990.72
Margin of safety
+33.2%
Implied growth (reverse DCF)
+4.2%
model assumes +10.8%
Value Score
30.7
Quality
58
Psychology
-20
Discovery
11.2
price/volume attention only
Moat score
15
erosion: watch

Value Score: bottom 42% of TOPIX 500 · Quality: bottom 44%

Dividend: 202/share (TTM) · yield 3.0% · payout 791%

Open the interactive Deep Dive for 4502.T →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/4502.T - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is 4502.T undervalued?

As of 2026-11-11, 4502.T trades at 6673 against a computed intrinsic value of 9990.72 (+33.2% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Takeda Pharmaceutical Company Limited's Value Score?

Takeda Pharmaceutical Company Limited's Value Score is 30.7 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does 4502.T pay a dividend?

Yes - 4502.T's trailing twelve-month dividend is 202/share, a yield of 3.0% at the current price (as of 2026-11-11).